ASX waiver on voting restrictions
(World News Science)

ASX RELEASE 16 December 2019 ASX WAIVER REGARDING VOTING EXCLUSIONS UNDER LISTING RULE 14.7 IN RELATION TO UPCOMING EGM Sydney, 16 December 2019 - Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that ASX has granted a waiver from Listing Rule 14.7 to the extent necessary to permit the Company not to comply with the voting exclusion statement in its notice of extraordinary general meeting (`Notice`) in relation to the resolution for the purposes of Listing Rule 7.1...